sericoside
olean-12-en-28-oic acid, 2,3,19,23-tetrahydroxy, glucopyranosyl ester
Identification
| Name | sericoside |
| CAS Number | 55306-04-2 |
| EINECS | 259-586-3 |
| FDA UNII | S4A9325KV4 |
| Molecular Formula | C36 H58 O11 |
| Molecular Weight | 666.84946000 |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 778.10 °C. @ 760.00 mm Hg (est) |
| Flash Point | 457.00 °F. TCC ( 235.80 °C. ) (est) |
| logP (o/w) | 2.356 (est) |
| Soluble in | water, 14.75 mg/L @ 25 °C (est) |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | skin conditioning |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | cosmetic agents |
| Recommendation for sericoside usage levels up to | not for fragrance use. |
| Recommendation for sericoside flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
beta-D-
glucopyranosyl (2alpha,3beta,4beta,19alpha)-2,3,19,23-tetrahydroxyolean-12-en-28-oate
olean-12-en-28-oic acid, 2,3,19,23-tetrahydroxy, glucopyranosyl ester
Google Patents:
Sericosides and method of use
PubMed:
Identification of natural metabolites in mixture: a pattern recognition strategy based on (13)C NMR.
PubMed:
Dimeric antioxidant and cytotoxic triterpenoid saponins from Terminalia ivorensis A. Chev.
PubMed:
Saponins and a lignan derivative of Terminalia tropophylla from the Madagascar Dry Forest.
PubMed:
[Triterpene saponins from Adinandra nitida].
PubMed:
Acceleration of lipid degradation by sericoside of Terminalia sericea roots in Fully differentiated 3T3-L1 cells.
PubMed:
Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle.
PubMed:
Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis.
PubMed:
Complex formation of sericoside with hydrophilic cyclodextrins: improvement of solubility and skin penetration in topical emulsion based formulations.
PubMed:
In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle.
PubMed:
Investigations on antimycobacterial activity of some Ethiopian medicinal plants.